The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: Long-term results

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1899-1906

  Maurer, C A ^a,b   Renzulli, P ^a   Kull, C ^b   Kaser S A ^b   Mazzucchelli, L ^a   Ulrich, A ^c   Buchler M W ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Hospital of Liestal   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAPELVIC MICROMETASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PELVIS TUMOR; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RADIATION STERILIZATION; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; RECURRENCE RISK; SEPSIS; SHORT COURSE THERAPY; SURVIVAL TIME; TOTAL MESORECTAL EXCISION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL SURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051552711     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1571-0     Document Type: Article

References (34)

1. Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg. 1995;82:1297-9.
2. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg. 1997;84:1731-6. (Pubitemid 27519608)
3. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg. 1982;69:613-6. (Pubitemid 12038080)
4. Maurer CA, Renzulli P, Meyer JD, Büchler MW. Rectal carcinoma. Optimizing therapy by partial or total mesorectum removal. Zentralbl Chir. 1999;124:428-35. (Pubitemid 29267919)
5. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133:894-9. (Pubitemid 28374285)
6. Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg. 1999;230:544-52.
7. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg. 2006;203:684-91. (Pubitemid 44648782)
8. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22:1785-96. (Pubitemid 41095168)
9. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group colo-rectal carcinoma. Tumori. 1995;81:60-4.
10. Kapiteijn E, Putter H, van de Velde CJ; Cooperative Investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002; 89:1142-9. (Pubitemid 34989221)
11. Bernardshaw SV, Øvrebø K, Eide GE, Skarstein A, Røkke O. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME-experience from one university hospital. Dig Surg. 2006;23:51-9. (Pubitemid 44174841)
12. Tilney HS, Tekkis PP. Extending the horizons of restorative rectal surgery: intersphincteric resection for low rectal cancer. Colorectal Dis. 2008;10:3-15. (Pubitemid 350238557)
13. Wu AW, Gu J, Wang J, et al. Results after change of treatment policy for rectal cancer-report from a single hospital in China. Eur J Surg Oncol. 2007;33:718-23. (Pubitemid 47039042)
14. Frileux P, Burdy G, Aegerter P, et al. Surgical treatment of rectal cancer: results of a strategy for selective preoperative radiotherapy. Gastroenterol Clin Biol. 2007;31:934-40.
15. Visser O, Bakx R, Zoetmulder FA, et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol. 2007;95:447-54. (Pubitemid 46709387)
16. Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM. Prevalence of patients with colorectal cancer requiring follow- up or active treatment. Eur J Cancer. 2009;45:1460-5.
17. Sadahiro S, Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology. 2003;50:1362-6. (Pubitemid 37186484)
18. Liang YC, Qing SH, Ding WX, Chen PY, Huang YB, Yu HT. Total mesorectal excision versus conventional radical surgery for rectal cancer: a meta analysis (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10:43-8.
19. den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since. 1990: The effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44:1710-6.
20. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B; Norwegian Rectal Cancer Group. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007; 94:113-21.
21. Peeters KC, Marijnen CA, Nagtegaal ID; Dutch Colorectal Cancer Group, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693-701. (Pubitemid 350035641)
22. Påhlman L. Population based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Tech Coloproctol. 2003;7:120-1. (Pubitemid 37046129)
23. Dahlberg M, Påhlman L, Bergström R, Glimelius B. Improved survival in patients with rectal cancer: a population-based register study. Br J Surg. 1998;85:515-20. (Pubitemid 28175448)
24. Heald RJ. The "holy plane" of rectal surgery. J R Soc Med. 1988;81:503-8.
25. Constantinides VA, Cheetham D, Nicholls RJ, Tekkis PP. Is rectal washout effective for preventing localized recurrence after anterior resection for rectal cancer? Dis Colon Rectum. 2008;51:1339-44.
26. Maurer CA, Z'Graggen K, Renzulli P, Schilling MK, Netzer P, Büchler MW. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg. 2001;88:1501-5. (Pubitemid 32989472)
27. Maurer CA, Z'graggen K, Zimmermann W, Häni HJ, Mettler D, Büchler MW. Experimental study of neorectal physiology after formation of a transverse coloplasty pouch. Br J Surg. 1999;86:1451-8. (Pubitemid 29525179)
28. Z'graggen K, Maurer CA, Birrer S, Giachino D, Kern B, Büchler MW. A new surgical concept for rectal replacement after low anterior resection: the transverse coloplasty pouch. Ann Surg. 2001;234:780-5.
29. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-9. (Pubitemid 16005611)
30. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-12.
31. Swiss Society of Gastroenterology. Revised consensus recommendations for surveillance of colorectal cancer surgically treated in curative intent. http://www.sggssg.ch/Dokumente/ Merkblaetter/NaSoCRCd.pdf (2007).
32. Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol. 2008;14:6018-23.
33. Sauer R, Becker H, Hohenberger W; German Rectal Cancer Study Group, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-40.
34. Frykholm GJ, Glimelius B, Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993;36:564-72. (Pubitemid 23177416)